Enterocloster bolteae

Show results for

Genomics (19)
Unknown (12)
Metabolomics (2)
Proteomics (2)

Organisms

Alphavirus (2)
Betaherpesvirinae (2)
Brassica oleracea var. oleracea (2)
Cowpox virus (2)
Coxsackievirus (2)
Cytomegalovirus (2)
Dengue virus (2)
EFO:0001352 (2)
Filoviridae (2)
Hepatitis B virus (2)
Human alphaherpesvirus 1 (2)
Human betaherpesvirus 5 (2)
Human immunodeficiency virus (2)
Human immunodeficiency virus 1 (2)
Human immunodeficiency virus 2 (2)
Influenza A virus (2)
Influenza C virus (2)
Japanese encephalitis virus (2)
Japanese encephalitis virus group (2)
Lyssavirus rabies (2)
Monkeypox virus (2)
Nostoc sp. PCC 7120 = FACHB-418 (2)
Oropouche virus (2)
Orthopoxvirus (2)
Orthopoxvirus vaccinia (2)
Rattus (2)
Ruditapes decussatus (2)
Tick-borne encephalitis virus (2)
Viruses (2)
West Nile virus (2)

Organisms

Enterocloster bolteae (3)
Enterocloster bolteae CAG:59 (2)
Enterocloster bolteae ATCC BAA-613 (1)
Enterocloster bolteae CC43_001B (1)
Enterocloster bolteae 90B8 (1)
Enterocloster bolteae 90B7 (1)
Enterocloster bolteae 90B3 (1)
Enterocloster bolteae 90A9 (1)
Enterocloster bolteae 90A5 (1)
Enterocloster bolteae WAL-14578 (1)

Repository

ENA (19)
MetaboLights (2)
pride (2)

Tissue

Cell culture (1)

Technology Type

Mass spectrometry (2)
Bottom-up proteomics (2)
Mass Spectrometry (2)

Instrument Platform

Liquid Chromatography MS - positive - reverse-phase (1)
Liquid Chromatography MS - negative - reverse-phase (1)
Liquid Chromatography MS - positive - reverse phase (1)
Liquid Chromatography MS - negative - reverse phase (1)

Publication Date

2025 (2)
2026 (1)
2024 (1)

Metabolite Name

1-O-[(3,8,9,24E)-12,15-Dihydroxy-26-oxo-3-{[(1R)-6-O-pentopyranosylhexopyranosyl]oxy}-9,19-cyclolanost-24-en-26-yl]hexopyranose (1)
1-O-[(3alpha,5xi,9xi,16alpha,18xi)-16-Hydroxy-28-oxo-3-{[4-O-(beta-D-xylopyranosyl)-beta-D-glucopyranuronosyl]oxy}olean-12-en-28-yl]-beta-D-glucopyranose (1)
1-O-((3,5.Xi.,9.Xi.)-3-((2-O-(6-Deoxy--L-mannopyranosyl)--L-arabinopyranosyl)oxy)-23-hydroxy-28-oxoolean-12-en-28-yl)-6-O--D-glucopyranosyl--D-glucopyranose (1)
4-[(7R,11S,14S,16R)-14-[(4-methoxy-6-methyl-5-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-7,11-dimethyl-2-oxapentacyclo[8.8.0.0a,l.0l,.0aa,a]octadec-5-en-6-yl]-2,5-dihydrofuran-2-one (1)
Respinomycin-A2 (1)
2-(2-{[2-(2-{[2-(2-{[2-(2-hydroxypropanamido)-3-methylbutanoyl]oxy}-3-methylbutanamido)-3-methylbutanoyl]oxy}propanamido)-3-methylbutanoyl]oxy}-3-methylbutanamido)-3-methylbutanoic acid (1)
Conophyllidine (1)
Vicibactin (1)
Odobromoamide (1)
(1S,2S,8,9,16,17)-1-(-D-Glucopyranosyloxy)-2,16,20-trihydroxy-9,10,14-trimethyl-11,22-dioxo-4,9-cyclo-9,10-secocholest-5-en-25-yl acetate (1)
(2R,3S,4S,5R,6R)-6-{[1,7-bis(4-hydroxyphenyl)heptan-3-yl]oxy}-5-{[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-2-({[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)oxane-3,4-diol (1)
(4E)-4-{2-[(1R,4aS,5R,6R,8aS)-6-Hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenedecahydro-1-naphthalenyl]ethylidene}-5-oxotetrahydro-3-furanyl (2E)-4-hydroxy-2-{1-hydroxy-2-[(1R,4aS,5R,6R,8aS)-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylenedecahydro-1-naphthalenyl]ethyl}-2-butenoate (1)
Afn A2 (1)
2-Ammonioethyl 1-[(9Z)-9-octadecenoyloxy]-3-(palmitoyloxy)-2-propanyl phosphate (1)
2,3,12-trihydroxy-4,6a,6b,11,12,14b-hexamethyl-8a-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicene-4-carboxylic acid (1)
(3beta,9xi)-3-{[4-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy}-14-hydroxybufa-4,20,22-trienolide (1)
Asperazine F (1)
Trichodepsipeptide (1)
Icosalide B (1)
Monamycin D(1) (1)
Basidiosin A (1)
Trichomide D (1)
Apicidin F (1)
Ulongamide B (1)
(2S)-N-[(2S,4S,5S)-5-{[(2,6-Dimethylphenoxy)acetyl]amino}-4-hydroxy-1,6-diphenyl-2-hexanyl]-2-(2,4-dioxotetrahydro-1(2H)-pyrimidinyl)-3-methylbutanamide (1)
(2R,3R,4S,5S,6R)-2-{[1,7-bis(4-hydroxyphenyl)heptan-3-yl]oxy}-6-({[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxane-3,4,5-triol (1)
Guineamide B (1)
Destruxin-Ed1 (1)
3-(3-sec-Butyl-6-isopropyl-5,8,9-trimethyl-1,4,7,10,14,17-hexaoxoicosahydropyrrolo[1,2-d][1,4,7,10,13,16]oxapentaazacyclononadecin-16-yl)-2-methylpropanoic acid (1)
3-[(3s,6r,9r,12s,13s)-5,8,11-trihydroxy-3-(hydroxymethyl)-6-(1h-indole-3-carbonyl)-12-methyl-13-[(2r)-octan-2-yl]-2-oxo-1-oxa-4,7,10-triazacyclotrideca-4,7,10-trien-9-yl]propanoic acid (1)

First Public Date

2013 (12)
2024 (2)
2022 (2)
2026 (1)
2025 (1)
2019 (1)

Release Date

2025 (5)
2023 (4)
2024 (3)

Lab affiliation

Department of Pharmacology & Therapeutics, McGill University, 3655 Prom. Sir-William-Osler, Montreal, Quebec, H3G 1Y6, Canada. (1)
Department of Pharmacology & Therapeutics, McGill University, 3655 Prom. Sir-William-Osler, Montreal, Quebec, H3G 1Y6, Canada. McGill Centre for Microbiome Research, Montreal, Quebec, Canada (1)

Tags

xref:PubMed:12747414 (1)

Previous page
1 / 4
You're on page 1
page 2
page 3
page 4
Next page

Sort by:

Relevance

Page size

Clostridium bolteae suppresses Enterobacteriaceae expansion and restores gut microbiome homeostasis via disrupting siderophore-mediated iron acquisition

Intestinal inflammation and the related gut microbiome dysbiosis are becoming prevalent worldwide. Overgrowth of Enterobacteriaceae exacerbates intestinal inflammation and gut microbiome dysbiosis. Enterobacteriaceae secrets siderophore to acquire iron and survive in the iron-limited gut. Therefo...

2026-01-03 | MTBLS13592 | MetaboLights

Untargeted proteomics on Enterocloster bolteae DSM 15670 Treated with urolithin C

Urolithin A is a polyphenol derived from the multi-step metabolism of dietary ellagitannins by the human gut microbiota which can affect host health. Most, but not all, individuals harbor a microbiota capable of urolithin A production; however, the enzymes that dehydroxylate its dietary precursor, u...

ORGANISM(S): Enterocloster bolteae ATCC BAA-613 Bacteria

2024-12-16 | PXD048514 | Pride

Untargeted proteomics of Enterocloster asparagiformis, E. citroniae, E. pacaense treated with DMSO or urolithin M6

Urolithins are a class of bioactive metabolites derived from the metabolism of dietary ellagitannins by the human gut microbiota. In the gut, urolithins are dehydroxylated regioselectively based on microbiota composition and activity. A single 9-hydroxy urolithin dehydroxylase (ucd) operon in gut re...

ORGANISM(S): Enterocloster hominis (ex Hitch et al. 2024) Enterocloster citroniae Enterocloster asparagiformis Bacteria

2025-11-12 | PXD066865 | Pride

Microbiome Dmso M6 Bacteria Enterocloster Urolithin

Enterocloster bolteae strain:AHG0001

Enterocloster bolteae strain:AHG0001 Genome sequencing and assembly

PRJNA491388 | ENA

Enterocloster bolteae RNA-seq

PRJNA904383 | ENA

Enterocloster bolteae CAG:59

Clostridium bolteae CAG:59 overview

PRJNA207238 | ENA

Ethanol-Producing Enterocloster bolteae Is Enriched in Chronic Hepatitis B-Associated Gut Dysbiosis: A Case-Control Culturomics Study.